en
At the 16th Drug Discovery Strategic Summit (DDSS) in San Francisco, Crystal Pharmatech will present the following content:
Small Molecule drug discovery scientists have been trained to believe that they need gram scale quantities of API to determine CMC properties such as solubility, oral absorption, and salt selection to understand the formulation strategy. Crystal Pharmatech will unveil its proven approach to understanding the developmental risks through focused laboratory work and the most advanced computational approaches. You will understand how, with only 10 mg of material, you can move from late lead-op to FIH with a line-of-sight of your compound’s development path and significantly enhance your probability of success in the clinic.
Attendee:
Robert Wenslow, Ph.D. (Speaker)
Ridwan Islam, Ph.D.
When: October 9-10, 2024
Where: San Francisco Airport Marriott Waterfront
Find Us: Booth #3
"The Best Use of 10 mg" — Achieve CMC Success through a Unique Optimization of Compound Benchwork and Computational Analysis
Subscribe to be the first to get the updates!
